A Study of Sublingually Administered (S)-Ketamine Oral Solution in Healthy Participants
Status:
Completed
Trial end date:
2020-08-17
Target enrollment:
Participant gender:
Summary
The purpose of this study is to characterize the plasma pharmacokinetic (PK) profile
following the single ascending dose (SAD) levels of an (S)-ketamine oral solution for
sublingual administration in healthy participants.